Unilever (OLLY / Liquid I.V.) Unpacked: What Their Latest Moves Signal for the Industry

United Kingdom — 24 August 2026

Unilever's strategic expansion into the wellness sector, particularly through acquisitions like OLLY and Liquid I.V., signifies a pivotal moment for the B2B supplement industry. These moves highlight the increasing convergence of mainstream FMCG with health and nutrition, driven by evolving consumer demands for convenient, efficacious solutions. For contract manufacturers and ingredient suppliers, Unilever's approach offers both significant opportunities and a clear indication of the escalating competitive landscape. The integration challenges faced by such large entities also provide crucial insights into market dynamics.

Company Snapshot

Unilever, headquartered in London, UK, is a multinational consumer goods company. While specific revenue figures for its Health & Wellbeing division are not publicly disaggregated to a granular level, the company reported overall turnover of €60.1 billion in 2025. Key wellness brands include OLLY (vitamins and supplements), Liquid I.V. (hydration solutions), and Nutrafol (hair wellness). Unilever operates in over 190 countries, employing approximately 127,000 people globally. The wellness portfolio represents a growing, albeit relatively small, proportion of its total revenue, estimated to be in the low single-digit billions for these specific brands.

Strategic Position and Recent Moves

Unilever's strategic posture in wellness is characterised by targeted acquisitions aimed at high-growth, consumer-centric niches. The acquisition of OLLY in 2019, reportedly for an undisclosed sum estimated at over $200 million, provided a strong foothold in the gummy vitamin market. This was followed in 2020 by Liquid I.V., acquired for a reported $600-800 million, bolstering its presence in functional hydration. More recently, the company acquired Nutrafol in 2022, a premium hair wellness brand, for an estimated $3.3 billion, further diversifying its health and beauty portfolio. These moves underscore a clear strategy to acquire agile, digitally native brands with strong consumer appeal, integrating them into Unilever's vast distribution networks while attempting to preserve their distinct brand identities. Product launches within OLLY and Liquid I.V. have focused on expanding existing lines, such as new flavour profiles for Liquid I.V.'s hydration multipliers and targeted functional gummies from OLLY, including stress and sleep variants. Market entries have largely leveraged Unilever's established global presence, introducing these acquired brands into new territories, particularly across Europe and Asia, over the past 12-24 months.

What Manufacturers Can Learn

Unilever's strategy reveals several critical trends for the supplement market. Firstly, consumer demand for convenient, palatable formats, such as gummies and powdered drinks, continues to drive innovation. Manufacturers should prioritise R&D into novel delivery systems that enhance user experience and bioavailability. Secondly, the emphasis on direct-to-consumer (DTC) models, initially employed by OLLY and Liquid I.V., highlights the importance of digital engagement and brand storytelling. Contract manufacturers capable of supporting brands with flexible production runs for DTC channels, alongside traditional retail, will be highly valued. Thirdly, the focus on specific, scientifically backed functional benefits—hydration, sleep, hair health—indicates a market moving away from general multivitamins towards targeted solutions. Manufacturers should invest in clinically validated ingredients and robust quality control to meet the stringent demands of larger players.

Risks and Headwinds

Despite its formidable market position, Unilever faces significant challenges in integrating these wellness brands. Maintaining the authentic, agile culture of acquired start-ups within a large corporate structure is notoriously difficult, potentially stifling innovation. There is also the risk of 'brand dilution' if the unique selling propositions of OLLY and Liquid I.V. are overly homogenised. From a regulatory perspective, the wellness sector is under increasing scrutiny, particularly regarding health claims and ingredient transparency. Unilever's scale means any misstep could attract significant regulatory attention, as seen with competitor Nestlé's challenges in certain health product categories. Furthermore, the market is highly competitive, with agile D2C brands continually emerging, alongside established players such as Procter & Gamble and Reckitt Benckiser also investing heavily in the health and nutrition space. The financial pressure to demonstrate significant ROI on multi-million and multi-billion-pound acquisitions adds considerable internal burden.

The B2B Verdict

Supplement businesses should absolutely be watching Unilever's wellness trajectory. Their acquisitions signal a clear direction for consumer preferences and market consolidation. For contract manufacturers and ingredient suppliers, this means adapting to higher volume demands, stricter compliance, and an increased focus on evidence-backed, consumer-friendly formats. Partnering opportunities exist for those who can offer scalable, innovative solutions that meet the rigorous quality standards of a global FMCG giant. Simultaneously, smaller brands should be prepared to compete on agility and niche specialisation, as Unilever's scale allows for aggressive market penetration and pricing strategies.